Poly-ϵ-caprolactone microspheres and nanospheres: an overview

VR Sinha, K Bansal, R Kaushik, R Kumria… - International journal of …, 2004 - Elsevier
Poly-ε-caprolactone (PCL) is a biodegradable, biocompatible and semicrystalline polymer
having a very low glass transition temperature. Due to its slow degradation, PCL is ideally …

Controlling drug nanoparticle formation by rapid precipitation

SM D'Addio, RK Prud'homme - Advanced drug delivery reviews, 2011 - Elsevier
Nanoparticles are a drug delivery platform that can enhance the efficacy of active
pharmaceutical ingredients, including poorly-water soluble compounds, ionic drugs …

Poly-ε-caprolactone (PCL), a promising polymer for pharmaceutical and biomedical applications: Focus on nanomedicine in cancer

SM Espinoza, HI Patil… - … Journal of Polymeric …, 2020 - Taylor & Francis
Abstract Poly-ε-caprolactone (PCL) has been the subject of extensive research in the past
few years. It is widely explored in drug delivery, where the development of nanomedicines …

Microparticle formation and its mechanism in single and double emulsion solvent evaporation

ID Rosca, F Watari, M Uo - Journal of controlled release, 2004 - Elsevier
The emulsification is the first step of the emulsification solvent evaporation method and has
been extensively investigated. On the contrary the second step, the solvent transport out …

Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology

B Singh, SK Chakkal, N Ahuja - Aaps Pharmscitech, 2006 - Springer
The aim of the current study was to design oral controlled release mucoadhesive
compressed hydrophilic matrices of atenolol and to optimize the drug release profile and …

Effects of crystalline microstructure on drug release behavior of poly (ε-caprolactone) microspheres

JC Jeong, J Lee, K Cho - Journal of controlled release, 2003 - Elsevier
This study investigates the release behavior of papaverine from poly (ε-caprolactone)(PCL)
microparticles prepared by the oil/water solvent evaporation method. Microparticles were …

Optimizing drug delivery systems using systematic" design of experiments." Part II: retrospect and prospects

B Singh, M Dahiya, V Saharan… - Critical Reviews™ in …, 2005 - dl.begellhouse.com
The first study on application of Design of Experiments (DoE) in optimizing drug formulation
appeared in 1967. Since then the number of literature reports on the use of DoE optimization …

Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis

V Natarajan, N Krithica, B Madhan… - Journal of pharmaceutical …, 2011 - Elsevier
Quercetin had been shown to be effective in the management of arthritis. However,
bioavailability of quercetin is a concern for such treatment. This work aims at the …

Production of haloperidol-loaded PLGA nanoparticles for extended controlled drug release of haloperidol

A Budhian, SJ Siegel, KI Winey - Journal of microencapsulation, 2005 - Taylor & Francis
This study developed an emulsion-solvent evaporation method for producing haloperidol-
loaded PLGA nanoparticles with up to 2%(wt/wt. of polymer) drug content, in vitro release …

An investigation into the role of surfactants in controlling particle size of polymeric nanocapsules containing penicillin-G in double emulsion

S Khoee, M Yaghoobian - European journal of medicinal chemistry, 2009 - Elsevier
Preparation, characterization and drug release behavior of loaded polybutyl adipate (PBA)
nanocapsules with penicillin-G are described here. The nanocapsules were produced using …